Skip to main content

Published locations for Dalfampridine’s effects on walking ability in MS extend to 24 weeks

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dalfampridine’s effects on walking ability in MS extend to 24 weeks

User login

  • Reset your password
  • /content/dalfampridines-effects-walking-ability-ms-extend-24-weeks
  • /internalmedicinenews/article/82515/multiple-sclerosis/dalfampridines-effects-walking-ability-ms
  • /internalmedicine/article/82515/multiple-sclerosis/dalfampridines-effects-walking-ability-ms-extend
  • /neurology/article/82515/multiple-sclerosis/dalfampridines-effects-walking-ability-ms-extend-24-weeks
  • /clinicalneurologynews/article/82515/multiple-sclerosis/dalfampridines-effects-walking-ability-ms